Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections JP Horcajada, M Montero, A Oliver, L Sorlí, S Luque, S Gómez-Zorrilla, ... Clinical microbiology reviews 32 (4), 10.1128/cmr. 00031-19, 2019 | 666 | 2019 |
Community infections caused by extended-spectrum β-lactamase–producing Escherichia coli J Rodríguez-Baño, JC Alcalá, JM Cisneros, F Grill, A Oliver, JP Horcajada, ... Archives of internal medicine 168 (17), 1897-1902, 2008 | 569 | 2008 |
Addition of a macrolide to a β-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia JA Martínez, JP Horcajada, M Almela, F Marco, A Soriano, MA Marco, ... Clinical Infectious Diseases 36 (4), 389-395, 2003 | 564 | 2003 |
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 473 | 2021 |
Community-Onset Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis J Rodríguez-Baño, E Picón, P Gijón, JR Hernández, M Ruíz, C Pena, ... Clinical infectious diseases 50 (1), 40-48, 2010 | 461 | 2010 |
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 441 | 2021 |
A Large Multicenter Study of Methicillin–Susceptible and Methicillin–Resistant Staphylococcus aureus Prosthetic Joint Infections Managed With Implant Retention J Lora-Tamayo, O Murillo, JA Iribarren, A Soriano, M Sánchez-Somolinos, ... Clinical infectious diseases 56 (2), 182-194, 2013 | 419 | 2013 |
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain J Berenguer, P Ryan, J Rodriguez-Bano, I Jarrín, J Carratala, J Pachón, ... Clinical Microbiology and Infection 26 (11), 1525-1536, 2020 | 359 | 2020 |
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 334 | 2021 |
Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH J Rodríguez-Baño, JR Pano-Pardo, L Alvarez-Rocha, Á Asensio, E Calbo, ... Enfermedades Infecciosas y Microbiología Clínica 30 (1), 22. e1-22. e23, 2012 | 322 | 2012 |
Relationship between biofilm formation and antimicrobial resistance in gram-negative bacteria V Cepas, Y López, E Muñoz, D Rolo, C Ardanuy, S Martí, M Xercavins, ... Microbial Drug Resistance 25 (1), 72-79, 2019 | 301 | 2019 |
Effect of meropenem-vaborbactam vs piperacillin-tazobactam on clinical cure or improvement and microbial eradication in complicated urinary tract infection: the TANGO I … KS Kaye, T Bhowmick, S Metallidis, SC Bleasdale, OS Sagan, V Stus, ... Jama 319 (8), 788-799, 2018 | 299 | 2018 |
The early systemic prophylaxis of infection after stroke study: a randomized clinical trial A Chamorro, JP Horcajada, V Obach, M Vargas, M Revilla, F Torres, ... Stroke 36 (7), 1495-1500, 2005 | 290 | 2005 |
Azithromycin in the treatment of COVID-19: a review D Echeverría-Esnal, C Martin-Ontiyuelo, ME Navarrete-Rouco, ... Expert review of anti-infective therapy 19 (2), 147-163, 2021 | 281 | 2021 |
Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials? M Vargas, JP Horcajada, V Obach, M Revilla, A Cervera, F Torres, ... Stroke 37 (2), 461-465, 2006 | 277 | 2006 |
Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance SM Soto, A Smithson, JA Martinez, JP Horcajada, J Mensa, J Vila The Journal of urology 177 (1), 365-368, 2007 | 272 | 2007 |
Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study L Sorlí, S Luque, S Grau, N Berenguer, C Segura, MM Montero, ... BMC infectious diseases 13, 1-9, 2013 | 249 | 2013 |
Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study N Benito, M Franco, A Ribera, A Soriano, D Rodriguez-Pardo, L Sorlí, ... Clinical Microbiology and Infection 22 (8), 732. e1-732. e8, 2016 | 237 | 2016 |
Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: a retrospective cohort study R Terradas, S Grau, J Blanch, M Riu, P Saballs, X Castells, JP Horcajada, ... Public Library of Science 7 (8), e42860, 2012 | 225 | 2012 |
Are Quinolone-Resistant Uropathogenic Escherichia coli Less Virulent? J Vila, K Simon, J Ruiz, JP Horcajada, M Velasco, M Barranco, A Moreno, ... The Journal of infectious diseases 186 (7), 1039-1042, 2002 | 220 | 2002 |